Business Wire

Mobilisation and Innovation for the 30th Edition of CARTES SECURE CONNEXIONS, a Singular Edition, Tinged with Emotion


This year’s CARTES SECURE CONNEXIONS took place from 17 to 19 November in the Paris-Nord Villepinte exhibition centre in unusual circumstances. In the aftermath of the tragic events in Paris of 13 November, which impacted us all, the exhibitor and visitor figures published in the traditional end-of-event press release reflect the resilience that participants wished to demonstrate at this time.

Despite the tragic events on 13 November 2015 in Paris, CARTES SECURE CONNEXIONS confirmed that it remains the must-attend event in the trust technologies industry.

Over 3 days, the world's Number 1 event in payment and identification technologies attracted a total audience of 15,090, including 1,800 CE0s. 135 countries were represented, making for turnout that was 77% international. 394 companies, 82% from abroad, exhibited their line-ups.

A place for doing business, interacting and engaging in reflection
CARTES SECURE CONNEXIONS 2015 offered an ideal setting for shared reflections and discussion about key issues and prospective responses, including numerous special talks that combined to offer a 360° view of the market.

The event started with a bang, as Uri Levine, Co-Founder of Waze and Feex, took to the stage as the Opening SUMMIT's keynote speaker. He is a serial start-upper, having sold his first start-up for over USD 1 billion to Google.
The CEOs of Spire, Infineon Technologies, Entrust Datacard and Worldline were also on the scene to share their vision of the sector.

A schedule bursting with more than 100 conferences on current and prospective issues featured 139 speakers. The three topics that attracted the largest audiences this year were:

  • HCE & Tokenization: What Role for the Secure Element?
  • e-Documents & e-ID as Drivers for Cross-Sector and Border Digital Services
  • New Business Models: What Impact on the Banking, Telco & Retail Industries?

11 Trophées SESAMES Awards were given on 17 November, including one Golden SESAMES, which went to Infineon for OPTIGA™ Trust E – enabling the IoT, a turnkey secured solution for automated industrial systems in domotics and personal devices.

The start-up Izicap won the Startup Challenge thanks to a marketing and loyalty-building solution that turns consumer bank cards into loyalty cards, and by the same token, makes payment terminals customer relations management tools in their own right.

The Innovation TV was one of the new additions in 2015, and hosted more than 50 speakers over the three-days.

Claire de Longeaux, the Exhibition's Director, shared her perspective: "CARTES SECURE CONNEXIONS 2015 opened its doors - just days after the 13 November attacks in Paris - under circumstances which no one could have imagined. We are all the more grateful and proud of the exhibitors, who made the extra effort so that the event could take place. On the visitors' end, yes, participation was lower than expected. Yet in that respect too, in our deeply-shaken environment, the industry came through and mobilised, and it is our pleasure to announce that CARTES SECURE CONNEXIONS was, once again this year, THE world's foremost event for payment and identification technologies. We already look forward to welcoming you to TRUSTECH 2016 next November.

Contact information

Stéphanie Champion
Cathy Bubbe
Clotilde de Angelis, tel : 01 42 30 81 00

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on